Citigroup
AMPE

Citigroup’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Citigroup’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16
Closed -$3K – 7846
2019
Q4 		$3K Hold
16
– – ﹤0.01% 7516
2019
Q3 		$2K Hold
16
– – ﹤0.01% 7575
2019
Q2 		$2K Hold
16
– – ﹤0.01% 7641
2019
Q1 		$3K Sell
16
-66
-80% -$11.3K ﹤0.01% 7503
2018
Q4 		$10K Sell
82
-95
-54% -$14.6K ﹤0.01% 7168
2018
Q3 		$27K Buy
177
+115
+185% +$48.1K ﹤0.01% 6946
2018
Q2 		$41K Sell
62
-130
-68% -$97.3K ﹤0.01% 6440
2018
Q1 		$196K Buy
+192
New +$161K ﹤0.01% 4987

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citigroup's AMPE Position: Q4 2022 in Review

Citigroup sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 2 shares.

Citigroup first reported a position in AMPE in Q4 2013 and held it in 32 quarters. The position peaked at $119K in Q4 2013. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Citigroup reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 2 Ampio Pharmaceuticals Inc. shares in Q4 2022.
  • Citigroup first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 32 quarters.
  • Citigroup's Ampio Pharmaceuticals Inc. position peaked at $119K in Q4 2013.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.